Cathie Wood Buys $69M Worth of Figma Stock on Blockbuster IPO Debut

Cathie Wood's ARK Invest ETFs significantly increased exposure to disruptive tech on July 31, notably acquiring 60,000 shares of newly-listed Figma (FIG) for approximately $69.30 million following its 250% IPO rally. Complementing this, ARK also added to positions in Prime Medicine, PagerDuty, AMD, and Nvidia, while strategically offloading shares in CRSPR Therapeutics, Adaptive Biotechnologies, and Roku. These trades reinforce ARK's ongoing conviction in high-growth technology and biotechnology sectors, reflecting its focus on disruptive innovation.

Analysis

ARK Invest executed a series of significant trades on July 31, underscoring its high-conviction strategy focused on disruptive innovation. The headline transaction was the acquisition of 60,000 shares of newly-listed Figma (FIG) by the ARK Next Generation Internet ETF (ARKW), a purchase valued at approximately $69.30 million. This move is particularly notable as it occurred after Figma's shares surged 250% on their first day of trading to close at $115.50 from an IPO price of $33. This aggressive entry into a high-momentum name was complemented by further investments in the technology and biotechnology sectors, including a $9 million purchase of Prime Medicine (PRME) and a $5 million addition to its PagerDuty (PD) position. ARK also reinforced its bet on the semiconductor industry by adding shares in both AMD and Nvidia (NVDA). Concurrently, the firm engaged in strategic selling, offloading $4.52 million of CRSPR Therapeutics (CRSP), $5.1 million of Roku (ROKU), and $2.1 million of Adaptive Biotechnologies (ADPT), likely to reallocate capital towards its newer, higher-conviction ideas.

Key Decisions for Investors

• ARK's substantial post-IPO investment in Figma (FIG) signals strong conviction in the high-growth software sector, however, investors should be cautious of the stock's elevated valuation following its 250% initial rally.
• The significant sales of CRSPR Therapeutics (CRSP) and Roku (ROKU) suggest a strategic reallocation of capital, prompting investors in these names to re-evaluate their positions in light of this institutional selling pressure.
• Continued accumulation of AMD and NVDA, even in smaller sizes, reinforces a bullish institutional outlook on the semiconductor sector, indicating that growth-focused managers may be using any price dips to increase exposure.